secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001437749-25-020081
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics appoints Jesper Høiland to board, replacing Joseph Vazzano
--------------------------------------------------------------------------------

- Joseph Vazzano resigned as director effective June 30, 2025.
- Jesper Høiland appointed director effective June 30, 2025; term expires at 2026 annual meeting.
- Høiland joins Audit, Compensation, and Nominating & Governance Committees.
- Høiland receives $50,000 annual retainer plus committee fees ($7,500/$5,000/$4,000).
- Høiland had served as strategic consultant since Oct 2024; background includes Novo Nordisk and Radius Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/0001437749-25-020081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/allr20250611_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer